It’s time to push back on drug price legislation
Sander Flaum wants pharma to push back on pricing legislation.
Drug Pricing
GOP, Dems agree on international reference price policy, but the devil is in the details
International reference pricing for drugs is great in theory, but Dems and the GOP are at odds over the details in each plan.
Want to save money on drug prices? Don’t listen to Washington
Sander Flaum urges Americans to ignore politicians’ calls to head north of the border for their prescription medication.
AARP on its latest drug price campaign: ‘There’s a lot of anger out there’
The organization has fighting words for Big Pharma.
4 takeaways from the PBM drug-price hearing on Capitol Hill
PBM execs were grilled on transparency, rebates and mega-mergers during Tuesday’s Senate Finance Committee hearing.
Live blog: PBMs face congressional grilling
The latest from the Senate Finance Committee’s grilling of executives from Cigna, CVS Health and CVS Caremark, Humana and OptumRx
Continued research depends on fair prices for treatments
Sander Flaum explains why continued research depends on fair prices for treatments.
Eli Lilly, Johnson & Johnson take initiative, get in front of PhRMA guidelines
Eli Lilly and Johnson & Johnson take the lead on PhRMA’s new guidelines for DTC ads.
First TV drug ad featuring list price debuts today
The spot for Johnson & Johnson blood thinner Xarelto comes ahead of a rule, proposed by the Trump administration in October, which would require drugmakers to disclose list prices in TV ads. The rule faces opposition from trade group PhRMA.
Expect legislative baby steps, not big leaps on drug prices
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
